文献速递中枢神经肿瘤放疗放疗物理与技术

脑肿瘤颅脑照射后脑放射性坏死的放射学诊断:系统综述

Radiological diagnosis of brain radiation necrosis after cranial irradiation for brain tumor: a systematic review.
PubMed 文献 · Radiat Oncol · 2019-02-06

该系统综述评估常规影像(CT/MRI)与核医学检查(SPECT/PET)鉴别脑放射性坏死与肿瘤进展的诊断准确性,检索至2015年3月,纳入20项和26项研究。钆增强MRI灵敏度最低(63%;95%CI:28-89%),联合多参数影像灵敏度最高(96%;95%CI:83-99%)。胶质瘤中钆增强MRI和18F-FDG-PET鉴别困难,转移性脑肿瘤中各种影像无差异。

要点

  • 钆增强MRI诊断脑放射性坏死的灵敏度最低(63%;95%CI:28-89%),诊断比值比也最低。
  • 联合多参数影像灵敏度最高(96%;95%CI:83-99%),诊断比值比也最高。
  • 胶质瘤中钆增强MRI和18F-FDG-PET的诊断比值比低,转移性脑肿瘤中各影像诊断比值比无差异。

核心结论

  • 对胶质瘤患者,使用钆增强MRI和18F-FDG-PET鉴别脑放射性坏死与肿瘤进展具有挑战性。
  • 对转移性脑肿瘤患者,任何放射学影像均可诊断脑放射性坏死。
  • 本综述提示,与单一影像检查相比,联合多参数影像(包括病灶代谢和血流)可能提高诊断准确性。
  • 然而,所综述研究存在显著偏倚风险和间接性,妨碍就诊断脑放射性坏死的最佳影像技术得出确切结论。

研究设计与样本

  • 系统综述,将诊断方法分为常规放射学影像(CT和MRI,RQ1)与核医学检查(SPECT和PET,RQ2)两类。
  • 图书管理员对PubMed、Cochrane图书馆和日本医学摘要学会进行截至2015年3月的全面系统检索。
  • 采用双变量随机效应模型估计汇总统计量,并按肿瘤类型(胶质瘤和转移性脑肿瘤)进行亚组分析。
  • 从数据库提取的188条和239条记录中,RQ1和RQ2分别纳入20项和26项研究进行分析。
  • 所有研究纳入的患者数量少,仅10项为无随机化的前瞻性研究。

主要发现

  • 在荟萃分析中,钆增强MRI表现出最低的灵敏度(63%;95%CI:28-89%)和诊断比值比。
  • 在所有影像研究中,联合多种影像检查表现出最高的灵敏度(96%;95%CI:83-99%)和诊断比值比。
  • 在胶质瘤亚组分析中,钆增强MRI和18F-FDG-PET显示低诊断比值比。
  • 在转移性脑肿瘤中,未观察到各放射学影像的诊断比值比存在差异。
  • 同一影像检查在不同研究间的诊断参数和研究对象常有差异。

关键数值与推荐

  • RQ1使用钆增强MRI、弥散加权成像、MR波谱和灌注CT/MRI诊断脑放射性坏死。
  • RQ2使用201Tl-SPECT、99mTc-MIBI-SPECT、99mTc-GHA-SPECT以及18F-FDG-PET、11C-MET-PET、18F-FET-PET和18F-BPA-PET。

局限性

  • 所有研究纳入的患者数量少。
  • 仅10项为无随机化的前瞻性研究。
  • 同一影像检查在不同研究间的诊断参数和研究对象常有差异。
  • 所综述研究存在显著偏倚风险和间接性,妨碍就诊断脑放射性坏死的最佳影像技术得出确切结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: This systematic review aims to elucidate the diagnostic accuracy of radiological examinations to distinguish between brain radiation necrosis (BRN) and tumor progression (TP). METHODS: We divided diagnostic approaches into two categories as follows-conventional radiological imaging [computed tomography (CT) and magnetic resonance imaging (MRI): review question (RQ) 1] and nuclear medicine studies [single photon emission CT (SPECT) and positron emission tomography (PET): RQ2]-and queried. Our librarians conducted a comprehensive systematic search on PubMed, the Cochrane Library, and the Japan Medical Abstracts Society up to March 2015. We estimated summary statistics using the bivariate random effects model and performed subanalysis by dividing into tumor types-gliomas and metastatic brain tumors. RESULTS: Of 188 and 239 records extracted from the database, we included 20 and 26 studies in the analysis for RQ1 and RQ2, respectively. In RQ1, we used gadolinium (Gd)-enhanced MRI, diffusion-weighted image, MR spectroscopy, and perfusion CT/MRI to diagnose BRN in RQ1. In RQ2, 201Tl-, 99mTc-MIBI-, and 99mTc-GHA-SPECT, and 18F-FDG-, 11C-MET-, 18F-FET-, and 18F-BPA-PET were used. In meta-analysis, Gd-enhanced MRI exhibited the lowest sensitivity [63%; 95% confidence interval (CI): 28-89%] and diagnostic odds ratio (DOR), and combined multiple imaging studies displayed the highest sensitivity (96%; 95% CI: 83-99%) and DOR among all imaging studies. In subanalysis for gliomas, Gd-enhanced MRI and 18F-FDG-PET revealed low DOR. Conversely, we observed no difference in DOR among radiological imaging in metastatic brain tumors. However, diagnostic parameters and study subjects often differed among the same imaging studies. All studies enrolled a small number of patients, and only 10 were prospective studies without randomization. CONCLUSIONS: Differentiating BRN from TP using Gd-enhanced MRI and 18F-FDG-PET is challenging for patients with glioma. Conversely, BRN could be diagnosed by any radiological imaging in metastatic brain tumors. This review suggests that combined multiparametric imaging, including lesional metabolism and blood flow, could enhance diagnostic accuracy, compared with a single imaging study. Nevertheless, a substantial risk of bias and indirectness of reviewed studies hindered drawing firm conclusion about the best imaging technique for diagnosing BRN.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Furuse M, Nonoguchi N, Yamada K, et al. Radiological diagnosis of brain radiation necrosis after cranial irradiation for brain tumor: a systematic review. Radiat Oncol. 2019. PMID: 30728041. doi:10.1186/s13014-019-1228-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。